| abstract |
Provided herein, inter alia, are methods for the diagnosis, prognosis, treatment, and prevention of cardiovascular events (e.g., arterial thrombosis, myocardial infarction) in subject having or suspected of having systemic lupus erythematosus including measurement of cardiovascular biomarkers, such as platelet-bound complement C4d, complement C3, and anti-phosphatidyl serine/prothrombin complex. |